| Market Cap | ₹9,896Cr |
| ROE | 11.05% |
| P/E Ratio(TTM) | 62.31 |
| EPS(TTM) | 30.65 |
| P/B Ratio | 6.91 |
| Dividend Yield | 0.00% |
| Industry P/E | 60.21 |
| Book Value | 276.43 |
| Debt to Equity | 0.14 |
| Face Value | 2 |
| Parent Organisation | Metropolis Healthcare Limited |
| Managing Director | Surendran Chemmenkotil |
| Founded | 1981 |
| NSE Symbol | METROPOLIS |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%) | 44.59 | ||
| Vijaya Diagnostic Centre | NA (0.00%) | 66.92 | ||
| Thyrocare Technologies | NA (0.00%) | 54.60 | ||
| Krsnaa Diagnostics | NA (0.00%) | 28.17 |